Nurix Therapeutics

NRIX

Market cap $1.63B

Upgrade to unlock

Buy

Hold

Sell

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$32

100% upside

High target

8 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Piper Sandler Joseph Catanzaro 25% 1-yr NRIX win rate				29 Jan ‘26 1 month ago
RBC Capital Brian Abrahams 0% 1-yr NRIX win rate				29 Jan ‘26 1 month ago
Stifel Stephen Willey 50% 1-yr NRIX win rate				29 Jan ‘26 1 month ago
Wells Fargo Derek Archila 50% 1-yr NRIX win rate				29 Jan ‘26 1 month ago
BTIG Jeet Mukherjee 50% 1-yr NRIX win rate				29 Jan ‘26 1 month ago
HC Wainwright & Co Robert Burns 57% 1-yr NRIX win rate				29 Jan ‘26 1 month ago
Needham Gil Blum 57% 1-yr NRIX win rate				29 Jan ‘26 1 month ago
Morgan Stanley Terence Flynn 0% 1-yr NRIX win rate				8 Jan ‘26 1 month ago